What Is 42 CFR Part 2? Definition & Examples

42 CFR Part 2 is the federal confidentiality rule for substance use disorder treatment records. It places special limits on how these records may be disclosed, with the goal of protecting patients from stigma, discrimination, and unnecessary exposure while still allowing legitimate treatment-related information sharing under defined conditions.

What 42 CFR Part 2 Covers

42 CFR Part 2 is not a general privacy slogan, it is a targeted confidentiality rule for substance use disorder treatment records. Its core purpose is to limit disclosure of highly sensitive records while still permitting defined treatment, payment, and healthcare operations uses under specific conditions.

The practical effect is that organisations must treat these records differently from ordinary health information. The rule can affect consent handling, redisclosure limits, segmentation of record sets, and the way information is shared across treatment partners, public health, legal, and administrative workflows.

Why the Rule Exists

Substance use disorder records carry a distinct stigma and discrimination risk, which is why the rule imposes stronger disclosure limits than many other record categories. The policy goal is to reduce the chance that patients avoid care because they fear unnecessary exposure of their treatment history.

That stronger protection does not mean records can never move. The rule is designed to allow legitimate care coordination, but only when the use case fits the allowed pathway and the organisation can show that the disclosure conditions have been satisfied.

How Disclosure Controls Work

42 CFR Part 2 is fundamentally about disclosure control, not just record storage. The compliance question is often who may receive the information, for what purpose, and whether the recipient is bound by the same limits on further disclosure.

In practice, organisations need to know whether a record is covered, whether a valid consent or other permission applies, and whether the recipient may re-disclose the information. That makes classification, access boundaries, and workflow design just as important as the policy text itself.

Because Part 2 can intersect with mixed medical records and integrated care systems, teams often need clear rules for separating covered data from broader clinical data. When that separation is weak, the organisation can accidentally expose more than the rule allows.

Operational Impact on Healthcare Organisations

This rule affects how healthcare, billing, legal, and health information teams design real workflows. If a system cannot reliably identify Part 2-protected data, the organisation may over-share by default or block disclosures that should be permitted for care.

For that reason, Part 2 usually becomes a governance issue as much as a legal one. Policies, training, system tagging, and access workflow design must all line up so staff can make the right disclosure decision quickly and consistently.

Modern interoperability can make this harder, especially when information moves across EHR integrations, referral networks, and external service providers. The more places the data flows, the more important it becomes to preserve the disclosure conditions that attached to it at the source.

Risk and Threat Considerations

Part 2 exists because improper disclosure can create harm even when no attacker is involved. The main risk is unauthorized exposure of highly sensitive treatment information, which can lead to stigma, discrimination, loss of trust, and downstream misuse by recipients who were never meant to see the record.

Failure mechanism: Weak data tagging, broad sharing defaults, incomplete consent handling, or poor segregation between Part 2 and general clinical data can cause protected information to move farther than the rule allows.

Impact: The result can be unlawful disclosure, regulatory exposure, patient harm, and a lasting loss of confidence in the care provider or health network.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

NIST CSF 2.0 and NIST SP 800-53 Rev 5 set the technical controls, while GDPR and ISO/IEC 27001:2022 define the regulatory obligations.

Framework	Control / Reference	Relevance
GDPR	EU General Data Protection Regulation	Sets lawful-processing and special-category data duties for sensitive health records.
Recommendation — Apply Article 9 and Article 32 controls to restrict disclosure and protect sensitive treatment data.
NIST CSF 2.0	PR.DS-01 — Data-at-rest is protected	Supports protecting sensitive records from unauthorized exposure and misuse.
	PR.AA-05 — Access permissions and authorizations are managed	Directly supports controlling who may access or receive sensitive records.
Recommendation — Classify Part 2 records and protect them with stronger handling and access boundaries. Enforce role- and purpose-based access rules before permitting disclosure of covered records.
ISO/IEC 27001:2022	A.5.12 — Classification of information	Part 2 depends on identifying and handling a special sensitive record class.
	A.5.15 — Access control	Controls who can view or share highly sensitive health information.
Recommendation — Mark Part 2-covered records explicitly so disclosure controls can follow the classification. Restrict access to Part 2 records to approved roles and approved purposes.
NIST SP 800-53 Rev 5	AC-6 — Least Privilege	Minimizes unnecessary exposure of protected treatment information.
	AU-2 — Event Logging	Supports accountability for access and disclosure of sensitive records.
Recommendation — Limit disclosure pathways and viewing rights to the minimum required for the approved purpose. Log access and disclosure events for Part 2 records so improper sharing can be investigated.

Practitioner Guidance

What to watch for: The most common operational failure is assuming that a system-level permission is enough when the disclosure rule actually depends on the specific record type, purpose, and recipient. Teams should verify that policy, workflow, and system labeling all point to the same decision.

Governance implication: Organisations handling substance use disorder records need clear ownership for classification, consent validation, and redisclosure controls. If those responsibilities are ambiguous, Part 2 becomes difficult to enforce consistently across integrated clinical and administrative environments.

42 CFR Part 2